Precision for Medicine acquires Redwood Outcomes, a Canadian HEOR firm – Pharmaceutical Commerce Magazine
Precision for Value, a unit of New York-based Precision for Medicine, is adding Redwood Outcomes, based in Vancouver, BC to its stable.
Commentary: Biosimilars – Why Deep Discounts May Become the Dominant Paradigm
Precision for Value’s Jeremy Schafer, Michael Tapella, and Thanos Kantarelis conclude that discounts in the biosimilar market may be significantly deeper than originally expected.
Precision for Value Acquires Redwood Outcomes – NJBIZ
Dan Renick is quoted in NJBIZ on Precision’s Redwood Outcomes HEOR acquisition.
Precision for Value Buys Health Economics Firm – Medical Marketing & Media
Precision’s acquisition of Redwood Outcomes is noted in Medical Marketing & Media.
Precision for Value Acquires Redwood Outcomes
Extends Leadership and Global Reach in Health Economics and Outcomes Research
Gladstone, N.J. and Vancouver, B.C., November 4, 2015 – Precision for Value (Precision) today announced that it has acquired Redwood Outcomes, a leading international health economics and outcomes research (HEOR) company. Redwood Outcomes serves pharmaceutical and biotechnology companies and applies the science of evidence generation, synthesis, and modeling to optimize healthcare decision making.